Allevetix Medical

Noninvasive Treatment for Type-2 Diabetes and Obesity

Health Tech & Life Sciences
Non Active, Aug 2025 ceased to operate
Series A Caesarea Founded 2017
LinkedIn
Total raised
$4.4M
Last: Series A 2018-06
Stage
Series A
Founded
2017
Headcount
1
HQ
Caesarea
Sector
Health Tech & Life Sciences

About

Allevetix Medical develops innovative medical technology focusing on the treatment of metabolic diseases such as type 2 diabetes, obesity, and nonalcoholic steatohepatitis.

The NobiX System is a nonsurgical, fully reversible, and natural treatment designed to mimic the effects of gastric bypass surgery without any need for cuts, ablations, or permanent changes to the patient's anatomy. It consists of a safe and noninvasive implant that prevents food contact with a section of the small intestine linked to hormone abnormality in the case of metabolic diseases.

Allevetix Medical is a subsidiary of Allium Medical Solutions, whose portfolio includes several companies specializing in the development, manufacture, and intentional marketing of medical products.

Funding history · 2 rounds · $4.4M total

2018-06
Series A $920K
Date unknown
Undisclosed $3.5M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

gastroenterologyobesitynon-invasivemedical-devicesdiabetesmedical-equipment